ArticleTranslational oncology2026
STC2-mediated calcium homeostasis dysregulation in the osteosarcoma microenvironment: Insights from single-cell sequencing and machine learning.
Article in Translational oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteosarcoma (OS) is an aggressive bone malignancy with a poor prognosis. Dysregulated calcium homeostasis may contribute to OS progression.
methodsVarious machine learning algorithms were integrated into multiple model combinations to identify key prognostic genes. Single-cell expression profiling was conducted to assess STC2 expression across different cell types within the OS microenvironment. Experimental validation was performed in OS cell lines (U2OS and 143B) using lentiviral shRNA-mediated knockdown, qPCR, proliferation assays, and migration/invasion assays. Immune infiltration and potential immunotherapy response were further explored using immune deconvolution, immune checkpoint analysis, TIDE, and SubMap.
resultsCalcium homeostasis-related dysregulation was associated with osteosarcoma progression, and machine-learning analysis identified STC2 as the most important prognostic gene. Single-cell analysis revealed that STC2 was predominantly expressed in endothelial, fibroblast, and malignant cells. In vitro experiments showed that knockdown of STC2 in OS cells significantly inhibited cell proliferation, migration, and invasion. Specifically, CCK-8, colony formation, and EdU assays demonstrated decreased cell proliferation, while Transwell assays revealed reduced migratory and invasive capacities of STC2-knockdown OS cells. Moreover, TIDE and SubMap analyses suggested that low STC2 expression was computationally associated with a higher predicted likelihood of response to immune checkpoint inhibitors.
conclusionsOur findings suggest that calcium homeostasis dysregulation is involved in OS progression and that STC2 is a prioritized prognostic and functional candidate within this network. The findings suggest that STC2 may serve as a potential therapeutic target and candidate biomarker for OS, including in the context of predicted immunotherapy response, although this requires further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.